Skip to content
Link copied to clipboard
Link copied to clipboard

DEA relaxes rules for the only federally approved drug derived from marijuana

On Monday, the DEA notified GW Pharma that it no longer considered Epidiolex a controlled substance under the federal Controlled Substance Act.

Epidiolex, a CBD drug derived from marijuana, was removed from the list of Controlled Substances on Monday.
Epidiolex, a CBD drug derived from marijuana, was removed from the list of Controlled Substances on Monday.Read moreGW Pharmaceuticals (custom credit) / HANDOUT
    by Sam Wood
    Published